相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulatory T cells: Their role in triple-negative breast cancer progression and metastasis
Rama Rao Malla et al.
CANCER (2022)
Copper in tumors and the use of copper-based compounds in cancer treatment
Daniela Almeida da Silva et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2022)
Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes
Yicheng Jiang et al.
NANOMEDICINE (2022)
Treatment landscape of triple-negative breast cancer - expanded options, evolving needs
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers
Nicole J. Toney et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Copper induces cell death by targeting lipoylated TCA cycle proteins
Peter Tsvetkov et al.
SCIENCE (2022)
Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
Alyssa Vito et al.
COMMUNICATIONS BIOLOGY (2021)
Serum Copper Level and the Copper-to-Zinc Ratio Could Be Useful in the Prediction of Lung Cancer and Its Prognosis: A Case-Control Study in Northeast China
Wenjun Wang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Prognostic value of tumor-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer
Hajime Kuroda et al.
BREAST CANCER (2021)
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
Shanshan Wang et al.
FRONTIERS IN GENETICS (2021)
Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
Xin-yu Ren et al.
FRONTIERS IN ONCOLOGY (2021)
Establishment and Validation of Prognostic Nomograms Based on Serum Copper Level for Patients With Early-Stage Triple-Negative Breast Cancer
Fangfang Duan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
D. Miles et al.
ANNALS OF ONCOLOGY (2021)
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
Peter Schmid et al.
LANCET ONCOLOGY (2020)
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita et al.
NATURE (2020)
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
K. G. K. Deepak et al.
PHARMACOLOGICAL RESEARCH (2020)
Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity
Yiwen Lu et al.
CELL (2020)
Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
Stefania Cocco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The molecular mechanisms of copper metabolism and its roles in human diseases
Ji Chen et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2020)
The physiological function of copper, the etiological role of copper excess and deficiency
Vetlenyi Eniko et al.
ORVOSI HETILAP (2020)
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
Gagan K. Gupta et al.
CANCERS (2020)
Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Masanori Oshi et al.
CANCERS (2020)
Serum copper and zinc levels in breast cancer: A meta-analysis
Yue Feng et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2020)
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Javier Cortes et al.
LANCET (2020)
The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
Pierre Lelievre et al.
CANCERS (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
Spontaneous mutations in the single TTN gene represent high tumor mutation burden
Ji-Hye Oh et al.
NPJ GENOMIC MEDICINE (2020)
Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis
Olga Karginova et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Correlations between microsatellite instability and the biological behaviour of tumours
Guang Yang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
Yin Wu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer
Shi-Chao Zhang et al.
JOURNAL OF CANCER (2019)
Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
Miseon Lee et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2019)
Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer
Cesar H. Saravia et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2019)
Identification of potential core genes in triple negative breast cancer using bioinformatics analysis
Man-Xiu Li et al.
ONCOTARGETS AND THERAPY (2018)
Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer
Soo Youn Bae et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
Mihriban Karaayvaz et al.
NATURE COMMUNICATIONS (2018)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
An overview of triple-negative breast cancer
Pankaj Kumar et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Serum Copper and Zinc Levels Among Iranian Colorectal Cancer Patients
Zahra Khoshdel et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2016)
Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics
Kyung Chan Park et al.
METALLOMICS (2016)
A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease
Joseph A. Pinto et al.
NPJ GENOMIC MEDICINE (2016)
Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
Esther H. Lips et al.
BREAST CANCER RESEARCH (2015)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency
Iuliana Shapira et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
How to build and interpret a nomogram for cancer prognosis
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Survival model predictive accuracy and ROC curves
PJ Heagerty et al.
BIOMETRICS (2005)
Metagenes and molecular pattern discovery using matrix factorization
JP Brunet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Copper and carcinogenesis
T Theophanides et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
分享论文
